Plasma Extracellular Vesicles in Meningioma Patients

ConditionMeningioma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity Hospital Heidelberg

About this trial

While surgical resection remains the primary treatment approach for symptomatic or growing meningiomas, radiotherapy represents an auspicious alternative in patients with meningiomas not safely amenable to surgery. Biopsies are often omitted in light of potential postoperative neurological deficits, resulting in a lack of histological grading and (molecular) risk stratification. In this prospective explorative biomarker study, extracellular vesicles in the bloodstream will be investigated in patients with macroscopic meningiomas to identify a biomarker for molecular risk stratification and disease monitoring.

Eligibility criteria

Qualifiers

confirmed meningioma (histologically or MRI/DOTATOC-PET CT)

macroscopic tumor in MRI (either as definitive RT, or following subtotal resection or relapse)

indication for radiotherapy

completed wound healing after surgical intervention)

Disqualifiers

previous or known tumor diseases < 5 years ago

previous (cerebral) radiotherapy

simultaneous chemo/immunotherapy

evidence that the patient cannot adhere to the study protocol (e.g., non-compliance)

Trial design

Treatments tested in this trial

  • Explorative biomarker study

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators